Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis
NCT04312113Phase 1Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Nov 2020
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in ulcerative colitis (UC), sponsored by Mayo Clinic. Primary endpoint: Number of participants with treatment-related adverse events at 24 months. Started Nov 2020; status: active, not recruiting.
02
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04312113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04312113.